# NAPROXEN SODIUM
> **ANDA202807** · Abbreviated New Drug Application (Generic) · Sponsor: CATALENT · Approved 2019-01-04
## Drug
- **FDA Application Number:** ANDA202807
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NAPROXEN SODIUM
- **Generic name:** NAPROXEN SODIUM
- **Active ingredients:** NAPROXEN SODIUM
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** CATALENT
- **Manufacturer:** P & L Development, LLC
- **First approval:** 2019-01-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202807)
---
*AI Analytics · CC0 1.0*